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Disclaimer. Specific recommendations provided here are intended as only a guide to clinical therapy, based on expert consensus 
and best current evidence. Treatment decisions for patients should be made by their responsible clinicians, with due consideration 
for individual circumstances. The most current version of this document should always be consulted.
HIV-positive children and adolescents are at increased risk of both central nervous system (CNS) sequelae and mental 
disorders owing to a number of factors, including the impact of HIV infection on the brain, social determinants of health 
(e.g. poverty and orphanhood) and psychosocial stressors related to living with HIV. Every effort should be made to identify 
perinatally HIV-infected children and initiate them on antiretroviral therapy early in life. HIV clinicians should ideally 
screen for mental health and neurocognitive problems, as part of the routine monitoring of children attending antiretroviral 
clinics. This guideline is intended as a reference tool for HIV clinicians to support the early identification, screening and 
management of mental health disorders and/or CNS impairment in children and adolescents. This guideline covers mental 
disorders (section 1) and HIV-associated neurocognitive disorders (section 2) among children and adolescents. 
S Afr J HIV Med 2014;15(3):81-96. DOI:10.7196/SAJHIVMED.1091
Untreated perinatally HIV-infected (PHIV) 
children are at increased risk of central 
nervous system (CNS) sequelae compared 
with HIV-infected children who begin 
antiretroviral therapy (ART) in infancy. HIV 
in vades the developing CNS earlier and with greater severity 
than observed in adults and with a more rapid progression 
to death. In addition, patients receiving ART may remain 
vulnerable to the effects of HIV on the brain because the CNS 
may be a reservoir for persistent viral replication. Initiation 
of ART, therefore, does not fully reverse CNS insults, 
particularly if treatment is not initiated during infancy.[1] 
Psychosocial stressors, such as poverty, orphanhood and 
parental illness (physical and mental), experienced by HIV-
positive children living in disadvantaged communities place 
them at further risk of poor educational and mental health 
outcomes. Furthermore, the onset of adolescence presents 
new challenges related to adherence issues, the provision 
of adolescent-friendly clinical environments, academic 
problems, mental health problems, and sexual and other risk 
behaviours.[2] 
1.  Mental disorders among 
HIV-infected children and 
adolescents
PHIV children present with high rates of mental disorders 
that exceed population norms and rates in other chronically ill 
children.[3] 
1.1  Overview of mental disorders in 
children and adolescents
Prevalence:
• In HIV-positive children, prevalence rates of 25 - 50% 
• Most common: attention deficit hyperactivity disorder 
(ADHD), mood disorders, anxiety disorders, substance use 
disorders (SUDs) (adolescents) 
• Less common: psychotic disorders, bipolar mood disorder
Risk factors:
• Previous AIDS-defining diagnosis, lower intelligence 
quotient, caregiver psychiatric disorder, parental loss, limit-
setting problems
Effects:
• Untreated psychiatric illness may affect ART adherence, and 
educational and medical outcomes
• Adolescents vulnerable to depression, non-disclosure, school 
failure/dropout, sexual risk behaviours and SUDs
1.2  Screening for mental disorders
• Accurate diagnosis requires a thorough history, and assess-
ment of the mental state of the child and of the family.
• Collateral information from the educator and/or extended 
family provides essential additional information. 
• The objective is to detect and refer suspected cases of 
children presenting with mental health disorders for a more 
comprehensive assessment. The detection of psychosocial 
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dysfunction is important as it may contribute to non-adherence and 
later treatment failure.[4]
• When screening for mental health problems, remember multiple 
interacting factors such as those within the child, home, school and 
external environment, all of which influence emotions/behaviour.
• No brief screening tool has been validated worldwide specifically 
for the detection of mental health disorders among HIV-positive 
children and adolescents. Table 1 presents some well-validated 
screening tools that may be utilised in primary care settings.
• A rapid screen of the commonly occurring mental disorders should 
be performed at the ART clinic and patients should be referred for a 
mental health assessment (Tables 2 and 3).
1.2.1 Referral criteria based on mental health screen
Refer or discuss the child with a mental health professional (mental 
health nurse, psychologist, child psychiatrist, psychiatrist) if the child 
presents with the following: 
• Symptoms of ADHD 
• Frequent or daily symptoms of anxiety that have affected functioning 
at home and at school
• Frequent or daily symptoms of depression/low mood, which have 
affected functioning at home and at school
• Suicidal ideas, intentions, plans or previous attempts
• Misuse of cannabis, methamphetamine, alcohol or any other illicit 
substance
• Confusion or change in behaviour/functioning from baseline
Refer or discuss with a social worker if additional information reveals 
the following:
• Maltreatment of the child (e.g. physical or sexual abuse)
• Adverse socioeconomic circumstances requiring assistance
• Limited or no parental care (child-headed household)
• Substance abuse
1.3  Assessment and diagnosis of mental 
disorders
Tables 4 and 5 outline the assessment and diagnosis of ADHD and 
major depressive episodes, respectively.
1.4  Assessment and diagnosis of anxiety 
disorders 
• Anxiety may present in children in a variety of ways (Table 6): 
• General symptoms include withdrawal, worries, fears, anticipation 
of threat and anxiety-themed dreams. These may be associated 
with vigilance/caution in anticipation of threat and avoidant 
behaviour. 
• Common physical symptoms include nausea and vomiting, 
headaches and abdominal cramps. Cardiovascular symptoms such 
as palpitations and dizziness are less common in children. 
• Anxieties may be related to worries about the child’s illness, the 
parent/caregiver, school, placement insecurity or the general 
environment. 
• Anxiety disorders that occur more commonly in childhood include 
separation anxiety disorder, selective mutism and specific phobias. 
• Adolescents may additionally present with social anxiety (social 
phobia) and panic disorder. The clinical presentation may more 
closely resemble that of adults. Generalised anxiety disorder may 
occur across the lifespan.[5] 
1.5  Assessment and diagnosis of psychotic 
disorders 
Neuropsychiatric symptoms in an HIV-positive child or adolescent 
include psychosis, severe mood disturbance, delirium or encephalo-
pathy. Psychotic symptoms (hallucinations, delusions, formal 
thought disorder) and mania are less common among HIV-positive 
children and adolescents compared with adults, and therefore have 
a high index of suspicion of a comorbid medical condition such as 
a CNS disorder. 
• Consider a psychotic disorder if there is a positive family history of 
mental illness, particularly schizophrenia or bipolar mood disorder.
• Suspect delirium if a patient presents with an acute onset of psychotic 
symptoms associated with confusion and clouding of consciousness 
that tends to fluctuate. Exclude general medical conditions (GMCs) 
such as seizures, meningitis, encephalitis, brain tumour or stroke. 
Failure to recognise delirium may delay the diagnosis of an underlying 
medical condition and may lead to an adverse outcome and even 
death.[5] 
Table 1. Validated screening tools for mental disorders in children and adolescents*
Screening 
instrument Clinical condition Source
SDQ (available in 
English, Afrikaans, 
Xhosa and Zulu)
Psychosocial 
functioning
http://www.sdqinfo.org/py/sdqinfo/b0.py
Conner’s scales 
(parent, teacher) 
ADHD http://www.doctorrudy.com/files/teacher_add_adhd_short.pdf
http://www.doctorrudy.com/files/add_adhd_parent_long.pdf
SNAP-IV rating 
scale
ADHD http://www.adhd.net/snap-iv-form.pdf 
Subscale of SDQ Depression www.sdqinfo.org/py/sdqinfo/b0.py
Paediatric 
symptom checklist
Psychosocial 
function
http://www.brightfutures.org/mentalhealth/pdf/professionals/ped_sympton_chklst.pdf
SCARED Anxiety http://www.psychiatry.pitt.edu/sites/default/files/Documents/assessments/SCARED%20Child.pdf
http://www.psychiatry.pitt.edu/sites/default/files/Documents/assessments/SCARED%20Parent.pdf 
SDQ = Strengths and Difficulties Questionnaire; ADHD = attention deficit hyperactivity disorder; SNAP-IV = Swanson, Nolan and Pelham, 4th revision; SCARED = Screen for Child Anxiety Related Disorders.
*  Consult the relevant International Academy of Child and Adolescent Psychiatry and Allied Professions (IACAPAP) book chapter, which provides an overview of clinical assessment of a child:  
http://iacapap.org/wp-content/uploads/A.5-CLINICAL-EXAMINATION-072012.pdf
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1.5.1 Delirium
• Delirium is a nonspecific neuropsychiatric disorder that occurs in 
medically ill patients, signifying global encephalopathic dysfunction. 
It commonly occurs across the age extremes (the very young and 
geriatric patients). However, it can occur in all ages, particularly 
in seriously ill patients with limited cognitive reserves and/or CNS 
conditions. It is well recognised in the elderly but underdiagnosed in 
children.
• Onset confers a poorer prognosis for an underlying medical condition.
• The core features comprise an altered level of consciousness, attention 
disturbances and diffuse cognitive deficits. Symptoms fluctuate and 
may present with behavioural disturbances (e.g. aggression) and 
perceptual disturbances, commonly visual hallucinations.
1.6 Differential diagnoses to consider 
• Schizophreniform disorder
• Schizophrenia
• Bipolar mood disorder: usually a history of a previous episode of 
elevated mood resulting in abnormal behaviour, e.g. decreased sleep, 
euphoria, hypersexuality, grandiosity and increased energy
• Mood or psychotic disorder secondary to GMC: HIV encephalopathy, 
seizures, tumours (frontal lobe), side-effect of efavirenz
• Substance-induced psychotic or mood disorder: cannabis, meth-
amphetamine
1.7  Mental status examination of the child 
or adolescent
The mental status examination of a child comprises observation of 
play, quality of caregiver-child interactions, verbalisations and also 
interpretation of drawings. The mental state of an adolescent more 
closely resembles that of an adult patient. 
1.7.1 Recording the mental state examination (MSE)
The MSE is an essential part of the psychiatric evaluation. The objective 
is to describe the child or adolescent’s appearance, behaviour, symptoms 
and cognitive functioning during the examination.
• Physical appearance: age, grooming, clothes, cleanliness, dysmorphic 
features, bruising, scars
• Behaviour and manner of relating to caregivers and interviewer: eye 
contact, ability to co-operate, quality of play, interaction with caregiver
• Mood and affect: range, type and appropriateness of affect (objectively 
euthymic, depressed, elevated)
• Anxiety: fears, separation difficulties, phobias
• Psychomotor behaviour: activity level, tics, co-ordination
• Content and form of thinking: delusions, preoccupations, 
ruminations, violence, anxiety  themes, thought disorder
• Speech and language: fluency, language skills, volume, rate
• Perceptual abnormalities: evidence of hallucinations (e.g. visual, 
auditory, olfactory)
• Overall cognitive ability: developmentally appropriate behaviour and 
drawings, general knowledge, vocabulary
• Attention, concentration and memory: attention and concentration, 
short- and long-term recall
• Level of consciousness: fluctuation, orientation for time, person and 
place
• Insight and judgement into own condition: acknowledgement 
of problem, attitude to receiving help, willingness to adhere to 
treatment, ability to judge hypothetical situations
1.8  Management of HIV-positive children 
and adolescents presenting with mental 
disorders
See Fig. 1, which summarises the assessment and management of HIV-
positive children presenting to primary care services.
1.8.1 Risk assessment
• Risk assessment includes evaluation of the following:
• Risk to self: suicidal thoughts or intent or self-harming behaviour; 
a patient may require hospitalisation in cases of a serious suicide 
attempt or intent
• Risk to others: thoughts or intention to harm others
• Risk-taking behaviour such as reckless driving, violence, 
disinhibited sexual behaviour, antisocial behaviour (engaging in 
unlawful acts) and unprotected sex  
• Additional risk to children is related to adverse child care, e.g. 
minimal parental/family or social support, neglect, physical, 
emotional or sexual abuse, abandonment.
1.8.2 Referral 
• Be aware of referral pathways in your own facility and local district. 
Communicate with colleagues providing mental health services 
at primary and district levels, such as a dedicated mental health 
nurse practitioner, psychiatric registrar, psychologist, occupational 
therapist and district psychiatrist. 
• Have a high index of suspicion for new-onset psychiatric 
symptoms that may present as a result of an acute or subacute 
infection or general medical condition, such as AIDS-defining 
infections, intracranial viral or bacterial infections, and delirious 
states due to substance abuse/withdrawal/infection or medica-
tion.
• Referral for any suspected mental health problems at primary level 
care should be to a mental health nurse practitioner (or psychiatric 
registrar, if available). Less severe or uncomplicated cases may be 
Children who have not been initiated on ART due to adequate 
CD4+ counts and who have psychiatric symptoms that are poorly 
responsive to antipsychotics may have detectible/high CNS viral loads 
despite undetectable serum viral loads (due to differing mutations 
in cerebrospinal fluid (CSF) and serum). These children should be 
initiated on ART, which may contribute to the resolution of psychotic 
symptoms. 
Children already on ART who have psychotic symptoms poorly 
responsive to antipsychotics should be assessed for a comorbid 
CNS disorder and/or have their ART regimen reviewed and a CNS 
penetrating regimen considered.[6] The Montreal Cognitive Assessment 
may be a useful screening instrument to detect cognitive impairment 
in adolescents. 
• https://pdbp.ninds.nih.gov/assets/crfs/Montreal Cognitive Assessment 
(MoCA)7_1.pdf 
• https://pdbp.ninds.nih.gov/assets/crfs/Montreal%20
Cognitive%20Assessment%20Scoring%20and%20Instructions.
pdf
The child should ideally be interviewed in his/her first language.
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managed at primary level in discussion with the district psychiatrist 
and mental health team at specialist level. 
• Complex cases (e.g. comorbid psychiatric and medical illness such 
as seizures, other CNS conditions, comorbid substance misuse and 
psychotic symptoms, catatonia and severe depression) should be 
referred to the district psychiatrist or specialist child and adolescent 
mental health (CAMH) services within the catchment area for 
assessment and possible hospitalisation. 
• Refer suspected cases of child abuse to the facility social worker, who 
may refer to an external social worker for statutory intervention.
• Refer to an occupational therapist at community level, who may 
do group-based interventions, or adherence groups and functional 
assessments. 
• Refer to the district psychologist for a psychological evaluation of 
the child and family. 
1.8.3 Liaison
• Communicate with the educator and school psychologist (with the 
family’s consent) to obtain accurate information. 
• Liaise with relevant adult services if you suspect parent or caregiver 
mental health problems. 
1.8.4 Attitude to family 
• Be sensitive and non-judgemental in your attitude. 
• Be aware of and attend to issues about stigma.
• Comply with the rules of confidentiality at all times.
Table 2. Detecting commonly occurring mental disorders among HIV-infected children
Interviewee Questions
Parent/
caregiver
ADHD Ask about level of activity, attention and impulsivity, e.g.: 
• Does the child struggle to sit still, move around constantly, fidget? 
• Is he/she able to concentrate on a task, focus on homework?
• Does he/she wait his/her turn or act without thinking?
Example answer: 
When he watches TV, he rocks and moves all the time and then gets up and walks/runs around. He looks around 
and interrupts conversations while he is doing his homework. He runs over the road without looking. 
Depression/
mood 
symptoms
• Is the child tearful, irritable, withdrawn from peers, disinterested in play most of the time? 
• Does the child talk about death or say he/she wants to die?
Example answer: 
She is moody and gets angry and cries quickly. She doesn’t want to play with her friends anymore. She used to like 
to play with her doll but now doesn’t want to. She sometimes says she wants to die.
Anxiety 
symptoms
• Does the child worry excessively, or feel fearful/scared?
Example answer: 
She is quiet and is scared of the dark and thunder. She worries that she will fail at school and worries about me 
(that I will get sick and die) and that there is no money. She talks about it all the time and it makes her not want 
to play or go to school.
Child School Tell me about school: 
• What do you like? What don’t you like about school? 
• Have you been in trouble at school? What for?
Example answer: 
I like my teacher and playing outside. I don’t like schoolwork (sums, reading out loud in class) and when the other 
children tease me or hit me. I was in trouble because I didn’t do my homework. 
Mood • What makes you happy or laugh a lot? 
• What makes you sad or want to cry?
Example answer: 
I am happy when I play with my friend and when I go out with my mommy to the shop. I cry when they argue or 
fight in the house. I feel sad when I stay long in hospital.
Anxiety • Do you have a lot of worries? 
Example answer: 
Yes, I worry that I am sick and that I have to go to hospital and may die. I worry about my mommy because she 
is sick too. I worry that she won’t be able to work anymore. I worry when it rains hard as the water may flood our 
house, and then we have nowhere to go. 
• Pick a feeling that you feel almost every day, e.g. happy, sad, scared, worried. (You may present the child 
with pictures of different faces.)
Example answer: 
I feel worried a lot, like every day.
Caregiver: 
academic 
enquiry
• Ask to see the latest school report
• Send the teacher Conner’s scale (ADHD screening tool) 
• Send a written request for information about the child
ADHD = attention deficit hyperactivity disorder.
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Table 3. Detecting commonly occurring mental disorders among HIV-infected adolescents
Interviewee Questions
Parent/
caregiver
• Is your adolescent very moody, tearful, sad and withdrawn? 
• Does your child ever say he/she wants to die or talk about attempted suicide?
• Is he/she worried, fearful/scared or complaining of nightmares? 
• Do you know if your adolescent has taken drugs or had unprotected sex?
Example answers: 
She locks herself in her room, is irritable, ignores us/doesn’t talk to us. I hear her crying in her room a lot. She worries 
that she will fail, says she can’t sleep and that she is having bad dreams. She sometimes says she wants to die/will kill 
herself. 
He smokes ‘weed’/’ganja’ with his friends. He has a girlfriend but I don’t know if they use condoms. 
Adolescent • Do you feel sad or worried, or feel like crying very often (every day or most days)? 
• Do you think about death or wanting to die? 
• Have you experimented with alcohol/drugs or had unprotected sex? 
Example answers: 
I feel bad, like low/down, so that I don’t feel like getting out of bed. I think all the time of bad stuff, like I’m going to die 
or be alone. 
Yea, I worry about a lot of stuff, that my boyfriend will leave me if he finds out I’m positive, that I’m going to fail or 
that I’m going to get sick as I keep forgetting to take the medicine for HIV. 
I smoke ‘weed’/’ganja’ with my friends and we drink brandy over the weekend. My girlfriend is on the injection so we 
don’t use condoms.
Caregiver/adolescent: 
academic enquiry 
Ask to see the latest school report. Ask the adolescent to report on his/her academic function and school, e.g.: 
• Tell me about school, e.g. your likes and dislikes? Are you ever in trouble at school? What for?
Ask the adolescent to report on his/her academic functioning and school, e.g.: 
• Tell me about school, e.g. likes and dislikes? Are you ever in trouble at school? What for? 
Send the teacher a copy of Conner’s scale or SNAP-IV to complete and a written request for information about the 
adolescent. 
SNAP-IV = Swanson, Nolan and Pelham, 4th revision.
Table 4. Assessment and diagnosis of ADHD[5]
DSM-V criteria Presentation in children Presentation in adolescents
Persistent inattention and/or hyperactivity/impulsivity 
Inattention symptoms (six or more of following): 
• Poor attention to details, careless mistakes
• Difficulty sustaining attention
• Does not listen
• Does not follow instructions
• Struggles to organise activities and tasks
• Task avoidant or dislikes tasks
• Loses things
• Easily distracted by external stimuli
• Forgetfulness
As per DSM-V criteria As per DSM-V criteria
Hyperactivity/impulsivity symptoms (six or more of following):
• Fidgety
• Leaves seat
• Runs or climbs when not appropriate
• Unable to play or engage in leisure activities
• Often ‘on the go’, acts ‘like a motor’
• Talks excessively
• Blurts out answers
• Struggles to wait turn
• Interrupts or intrudes on others
As per DSM-V criteria Hyperactivity symptoms may 
wane but impulsivity persists 
in some cases to adulthood
ADHD = attention deficit hyperactivity disorder; DSM-V = Diagnostic and Statistical Manual of Mental Disorders (5th edition).
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1.8.5  Management of depression and anxiety in HIV-
positive children and adolescents
• Conduct a thorough history and clinical assessment. This includes 
information about functioning at school.
• Interview the child/adolescent alone and with the caregiver.
• Initiate first-line psychosocial intervention, i.e. address precipitating 
or perpetuating stressors, e.g. bullying, stigma. Refer the child 
for play/individual/group therapy if resources are available and 
according to the child’s intellectual ability; alternatively, refer to the 
school counsellor. Refer parents to local parenting groups and/or for 
their own psychological or psychiatric interventions as necessary.
• For moderate to severe symptoms, initiate selective serotonin 
re-uptake inhibitor (SSRI) in addition to psychosocial management. 
• Initiate with a low dose and titrate slowly, preferably with 
citalopram 5 mg or 10 mg daily, or fluoxetine 5 mg or 10 mg daily 
if citalopram is not available. (Administer by opening a capsule 
into 20 ml of orange juice to create a 1 mg/ml solution. Use a 5 ml 
or 10 ml syringe to measure out the daily dose. Keep the remainder 
refrigerated.) 
• Titrate up to the therapeutic dose (as per EDL). 
• Monitor adolescents or older children closely for suicidal ideation 
and SSRI side-effects, e.g. behavioural disinhibition or activation. 
• Review in 1 month. Titrate up to 10 - 20 mg (or beyond up to a 
maximum of 30 - 40 mg) if indicated and if there are no adverse 
side-effects. 
• Reassure the patient and parent that most side-effects are transient 
and dose related.
• Refer a child with moderate to severe symptoms and with poor 
response to treatment to a local child psychiatric service if available, 
or discuss with a psychiatrist (or child psychiatrist if available).
• Treatment for depression should ideally be for 6 - 12 months after 
symptom resolution, after which the patient may be weaned off medica-
tion. Discuss with a mental health professional or child psychiatrist.
• Treatment duration for anxiety disorders is usually 6 - 12 months after 
symptom resolution. However, treatment duration and discontinuation 
of medication management should be individualised according to the 
specific anxiety disorder, severity, recurrence and treatment response. 
Discuss with a mental health professional or child psychiatrist.
1.8.6  Management of ADHD in HIV-positive children 
and adolescents
• Conduct a thorough history and clinical assessment. It is important 
to include all spheres of the child’s environment (including home, 
school and peers).
• Ask the parent and teacher to complete a Connor’s or SNAP report.
• Establish baseline weight and height, and calculate and plot body 
mass index (BMI).
• Initiate psychosocial intervention, including support for parents and 
teachers, input on positive reinforcement, and establishing structure 
and routine in the child’s day. Refer parents to a local parenting group 
if available.
• If indicated, initiate stimulant medication. The dosage should be 
based on the child’s age and weight, i.e 1 mg/kg body weight/day. 
• In children 6 years and older, start with 5 mg short-acting 
methylphenidate 2 - 3 times daily (5 mg every 3 - 3.5 hours), e.g. 
initiate 5 mg at 07h30, 5 mg at 11h00 and 5 mg at 14h30. Increase 
weekly by 5 - 10 mg, but do not exceed 30 mg daily. 
• Alternatively, in older children or adolescents, initiate long-acting 
methylphenidate 20 mg daily at 07h30, if available. 
• Medication should be initiated only after confirmation of the diagnosis 
by a psychiatry registrar, medical officer or district psychiatrist. 
Fluoxetine or citalopram may be prescribed for moderate to severe 
depression and anxiety disorders. Citalopram is preferable because 
of potential drug-drug interactions between fluoxetine and certain 
antiretroviral medications. Fluoxetine can increase agitation and 
impulsivity, so monitor closely.
Table 5. Assessment and diagnosis of major depressive episode[5]
DSM-V criteria Presentation in children Presentation in adolescents
• Depressed mood almost all day, every day
OR
• Loss of interest or enjoyment of usually pleasurable 
activities for most of the day
• Irritable mood, tearfulness
• Loss of interest in play, toys or friends
• Decline in academic performance
• Similar to adults 
• Irritability
• Social withdrawal from peer group
AND 
• Diminished pleasure or interest in most activities, 
most of the day 
• Significant weight loss (i.e. >5 kg)
• Insomnia or hypersomnia (inability to sleep/
excessive sleep) 
• Psychomotor agitation or retardation 
• Loss of energy or fatigue
• Feelings of worthlessness or inappropriate, excessive 
guilt 
• Decreased ability to think or concentrate, or 
indecisiveness (either by subjective account or as 
observed by others)
• Thoughts of death that are recurrent, or recurrent 
suicidal ideation without a specific plan, or a specific 
plan for committing suicide or a suicide attempt 
• Somatic complaints such as abdominal 
pain and/or headache
• Suicide risk may increase
DSM-V = Diagnostic and Statistical Manual of Mental Disorders (5th edition).
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• Use the lowest effective dosage. 
• Educate parents about effects and possible side-effects. 
• Review the child in one month. Check pulse and blood pressure. 
If abnormal, do an electrocardiogram (ECG), lower the dosage 
and continue to monitor. Medication should be discontinued if 
an ECG abnormality is detected and/or cardiovascular disease is 
observed. Refer to a cardiologist if a cardiovascular abnormality 
is detected.
• Assess response to methylphenidate through direct observation and 
feedback from teachers and parents. 
• Assess weight and height and plot BMI at each visit. If there is loss 
of appetite, encourage the parent to provide additional calories and 
snacks such as a peanut butter sandwich at night for extra protein. 
Stop treatment if growth curve flattens or there is significant weight 
loss >5 kg.
1.8.7  Management of children presenting with 
psychotic symptoms and/or mania 
• Complex cases should ideally be referred for neuropsychiatric 
assessment and further investigation (including CNS investigation 
and neurocognitive testing) at a tertiary-level service. 
• Behaviourally disturbed psychotic adolescents should be referred for 
admission.
• Exclude delirium before considering a primary psychotic illness. 
Investigations such as chest X-ray, full blood count, temperature, 
pulse and urine dipsticks can be used to screen for delirium before 
referring to secondary level for further investigations such as 
lumbar punctures and/or neuroimaging.
Table 6. Overview of anxiety disorders in children and adolescents
Anxiety disorder DSM-V criteria Clinical presentation in children
Separation anxiety disorder • Excessive fear of separation from attachment 
figure that is inappropriate for developmental 
stage
• Stays close to parent and refusal to be away from 
home. Could lead to school refusal
• Becomes very distressed when separated
• Worries that attachment figure will not come 
home, or will become ill, become a victim of an 
accident, or will die
Selective mutism • Failure to speak in situations or environments 
where there is an expectation for speaking, e.g. 
school. Interferes with normal functioning
• Not associated with language problem. No 
associated communication disorder
• The child fails to speak or reciprocate with 
speech when spoken to
• The child speaks freely at home or when alone 
with familiar family figures
• Child is anxious in social situations
• May lead to academic problems and social 
difficulties
Specific phobia • Marked anxiety or fear about a specific situation 
or object e.g. animals, injections, heights, blood
• Fear is out of proportion to the danger posed by 
the object or situation
• Persistent and lasts 6 months or longer
• Causes significant distress and impairment
• The object of phobia evokes an immediate and 
extreme reaction
• The fear is expressed by tantrums, crying, 
clinging or freezing
Social anxiety disorder (social 
phobia) 
• Social situations evoke fear or anxiety, when 
the individual is exposed to scrutiny by others 
(conversations, being observed, meeting unfamiliar 
people, delivering a talk in front of class or large 
group)
• The person fears humiliation or embarrassment
• The social situation is endured with extreme 
discomfort or avoided
• Occurs among peers
• The anxiety may be expressed by freezing, 
tantrums, clingy behaviour, crying or failure to 
speak
Panic disorder • Feelings of intense discomfort and fear associated 
with physical symptoms such as sweating, 
palpitations, shaking, chest pain, nausea, chills or 
feeling hot, and numbness/tingling sensations
• Abrupt onset and peaks within minutes
• Onset may be from a calm or anxious state
• Intense fears of losing control or death
Generalised anxiety disorder • Excessive uncontrollable worry and anxiety 
occurring most days for longer than 6 months
• Requires three of six accompanying symptoms: 
poor sleep, fatigue, muscle tension, poor 
concentration, restlessness and irritability
• Causes distress and significant impairment in 
functioning
• Asks constant questions and seeks reassurance
• Complains of headaches and abdominal cramps
• Anxiety dreams, e.g. of being chased, storms, 
wild animals
• Requires only one of six accompanying 
symptoms: poor sleep, fatigue, muscle tension, 
poor concentration, restlessness and irritability
DSM-V = Diagnostic and Statistical Manual of Mental Disorders (5th edition).
There are no known drug-drug interactions between methyl-
phenidate and antiretroviral medications.
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• Antipsychotics may be initiated at low doses, but with caution and after 
discussion with a psychiatrist. Initiate risperidone 0.5 - 1 mg daily and 
increase the dose by 0.25 - 0.5 mg daily every 1 - 2 weeks, depending 
on tolerance and age of the child. Refer for admission to tertiary 
CAMH or psychiatric unit if doses in excess of 3 mg are required.
1.8.8 Medication management
• Do not prescribe psychotropic medication to children or 
adolescents if there is diagnostic uncertainty and/or there has not 
been a thorough psychiatric assessment and consultation with a 
specialist. 
• It is important to be cautious about the use of psychotropic 
medications in the management of behaviour disorders in the context 
of HIV because of high pill burden and potential drug interactions. If 
medications are not seen to be working, they should be discontinued 
and polypharmacy should be avoided.
• Initiate at lower doses and increase slowly. Monitor for untoward 
side-effects. 
• Be aware of drug-drug interactions between certain antiretroviral 
and psychotropic medications (particularly SSRIs) (Table 7).
• Be aware of neurological and psychological side-effects of some 
antiretroviral medications.
1.8.9  Other diagnoses or symptomatology to consider 
as part of the assessment and management of 
HIV-positive children and adolescents 
1.8.9.1 Suicide 
• Definition: deliberate self-harm where the intention is to die.
• A suicide risk assessment is essential in the assessment of all patients 
with HIV presenting with psychiatric symptoms such as depression, 
anxiety, psychosis or self-harming behaviour. 
• Suicide attempts in children and adolescents may be impulsive and 
often related to an intercurrent stressor, which may not always be 
severe. However, the outcome may be fatal.
Suicide risk assessment
High suicide risk is indicated by any one or more of the factors below:
• Previous suicide attempt
• Pre-existing mental illness
• Family history of suicide
• Substance abuse
• Gender (adolescent males are at increased risk of completed suicide; 
adolescent females make more suicide attempts)
The following may further contribute to risk:
• Stressful life events
• Physical and sexual abuse
• Poor parent-child communication
Management of suicidal ideation
• Assess suicide risk severity. 
• Screen for and treat underlying mental illness, especially 
depression.
• Develop a safety plan in collaboration with the patient and family. 
• Consider hospitalisation if assessment indicates high risk.
• Do not discharge without an adequate psychiatric evaluation if high risk.[7]
1.8.9.2  Management of trauma-related disorders in 
children and adolescents with HIV
• Psychosocial counselling and support strategies include compassion-
ate early debriefing, family support and psychoeducation. 
• Psychotherapy: cognitive behaviour therapy is useful.
Table 7. Commonly used psychotropic medications and their interactions*
Class Drug Possible side-effects Possible drug interactions
SSRIs Fluoxetine Headache, nausea/vomiting, behavioural 
activation
Potential increase in efavirenz levels
Citalopram Headache, nausea/vomiting -
Antipsychotics
  FGAs Haloperidol EPSEs (dystonia, tremor, akathisia, 
cogwheeling, bradykinesia), neuroleptic 
malignant syndrome 
-
  SGAs Risperidone EPSEs at higher doses, sedation, weight 
gain, metabolic syndrome
Possible interactions with protease inhibitors
Olanzapine Sedation, metabolic syndrome, CVS side-
effects
Probable interactions with protease 
inhibitors
Clozapine Best to avoid without specialist support Probable interactions with protease 
inhibitors
Mood stabilisers Lithium carbonate Toxicity, which may be life threatening Avoid with tenofovir
Sodium valproate Sedation, thrombocytopenia, toxicity -
Lamotrigine Stevens-Johnson syndrome Possible interactions with protease inhibitors
SSRIs = selective serotonin re-uptake inhibitors; FGAs = first-generation antipsychotics; EPSEs = extrapyramidal side-effects; SGAs = second-generation antipsychotics; CVS = cardiovascular.
* Source: http://www.druginteractions.org
 SEPTEMBER 2014, Vol. 15, No. 3   SAJHIVMED     89 
G
U
ID
ELIN
E
• Medication such as SSRIs may be indicated if there is a poor response 
to treatment or severe symptoms. 
• Check for alcohol and substance abuse in older adolescents.
• Refer to specialist care if there is a poor response to treatment.[8,9] 
Post-traumatic stress disorder 
• Post-traumatic stress disorder (PTSD) can occur when a person 
has experienced, witnessed or been confronted with an event that 
involves actual or threatened death, harm or injury, to themselves or 
to others, with resultant shock, fear, helplessness or horror. 
• The prevalence of PTSD in adolescents living with HIV is not 
known, but studies report a prevalence range of 15 - 64% in 
adult samples, suggesting that PTSD may also be common in 
adolescents.[9]
• Children may have significant symptoms of PTSD but may not 
meet full Diagnostic and Statistical Manual of Mental Disorders (5th 
edition) (DSM-V) criteria (Table 8), as they may have difficulty 
verbalising their emotions. 
1.8.9.3 Adjustment disorders
• An adjustment disorder is the development of a behavioural or 
emotional response to an identifiable stressor within 3 months of 
the stressor, resolving within 6 months of termination of the stressor. 
• Patients may present with depressive, anxiety and/or behavioural 
symptoms but do not meet criteria for depression, anxiety or 
disruptive behaviour disorders.[4] 
• Treatment for adjustment disorders includes supportive psychotherapy and 
improving coping mechanisms. Short-term medication may be considered.
• Children and adolescents with HIV in Africa often have multiple 
psychosocial challenges/stressful life events that make them more 
emotionally vulnerable and isolated.[10] 
• The effect of the virus is thus compounded by negative life events 
that further negatively affect neurocognitive development. 
Common stressful life events for HIV-positive children
• Ill caregiver who cannot cope with parenting
• Death of caregiver 
SUSPECT PRIMARY
MENTAL DISORDER
ADHD DEPRESSION ANXIETY
IDENTIFY
Stressful life events
(may impact on mental 
health and adherence)
Grief/bereavement: refer
for counselling
Non-adherence in
adolescents: refer to adherence
group/counsellor
Substance abuse and risk-
taking behaviours: refer to 
social worker/mental health
nurse
Child abuse
(physical, emotional,
 sexual): refer to social worker
Learning diculties,
cognitive decline:
see section 2)
Address
stressors
Family and
parenting
Individual
and/or group
therapy
• SSRI:
citalopram
• Family,
group,
individual
intervention
SSRI:
citalopram
•
•
•
•
Refer to
Department of
Education for
psychometric
testing, remedial
teaching
• Parenting
Behaviour-
based
management
•
Stimulant
medication
•
SCREENING
Primary or ART site
DIAGNOSIS/REFERRAL
Refer to mental health nurse/psychiatry
registrar for assessment/diagnosis
Discuss with district psychiatrist
Refer to tertiary service if complex
presentation/suicide risk/admission
Refer to adherence group if available
MANAGEMENT
Exclude GMCs (encephalopathy,
seizures, stroke, CNS tumour) and
refer appropriately
Beware misdiagnosis of 
psychosis may be delirium
Fig. 1. Recognising primary mental disorders in HIV-positive children and adolescents. (ART = antiretroviral therapy; ADHD = attention de cit hyperactivity 
disorder; GMCs = general medical conditions; CNS = central nervous system; SSRI = selective serotonin re-uptake inhibitor.)
Table 8. PTSD criteria in children and adolescents
DSM-V criteria Presentation: preschooler Presentation: child Presentation: adolescent
• Onset after experiencing or witnessing a serious 
traumatic event (e.g. rape, assault, accidents)
• Symptoms may occur soon after the event or with 
delayed onset 
• Symptoms: intrusive memories (reliving, flashbacks, 
nightmares), hyperarousal (increased startle response, 
anxiety symptoms), avoidance (avoiding situations that 
remind of the traumatic event, numbing, feeling of 
foreshortened future)
Nightmares, inconsolable 
crying, repetitive play 
of traumatic content, 
regression, e.g. bedwetting
Fearful, repetitive play, 
traumatic content in 
drawings, hyperarousal 
and avoidance of 
painful stimuli, poor 
concentration, temper 
tantrums
Similar to adults
PTSD = posttraumatic stress disorder; DSM-V = Diagnostic and Statistical Manual of Mental Disorders (5th edition).
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• Multiple caregivers or child-headed 
households
• Sick siblings
• Poverty
• Multiple hospital visits
• Disrupted schooling
• Disclosure issues
• Stigma
Grief and bereavement
• Children may lose one or both parents to 
AIDS and are then often separated from 
siblings and moved about in an attempt to 
continue to provide for their basic physical 
needs. 
• These children are often left fearful and 
anxious or confused.
• In addition, HIV-positive children may 
have fears about their own mortality. 
• It is important that children be allowed 
to express their grief. Grief reactions are 
influenced by the child’s developmental age 
and coping mechanisms (Table 9).
• Very young bereaved children may 
experience regression such as thumb sucking, 
have nightmares or become clingy. They may 
also present with acting-out behaviours. 
• Bereavement in older children may 
pre sent with aggressive or impulsive 
behaviour, poor performance at school, 
and/or poor concentration or emotional 
outbursts.[11]
• Supportive therapy/counselling at a develop-
mentally appropriate level of the child and 
family is the mainstay of treatment.
 1.8.9.4  The disruptive and aggressive 
child and adolescent 
• A high prevalence of challenging or disruptive 
behaviours exist in HIV-positive children and 
adolescents, including ADHD, ADHD-like 
impulsivity and hyperactivity, aggression, 
oppositionality and conduct disturbances.[2]
• However, aggression and disruptive behav-
iours may arise from medical problems in the 
child or adolescent, or may be a manifestation 
of a mood or anxiety-related problem. 
• Adolescents in particular struggle with 
mood and behavioural regulation. 
• There is no direct link between HIV itself 
and disruptive behaviour. Factors such 
as poverty, prenatal alcohol and drug 
exposure, malnutrition, family disruption, 
social chaos and educational deprivation 
may play a role. 
Table 10. Conduct disorder in children and adolescents
DSM-V criteria Presentation: child Presentation: adolescent
Aggression towards people and animals
• Frequent threats, bullying or intimidation of 
others
• Frequently initiating physical fights
• Use of a weapon that can cause serious physical 
harm to others
• Physically cruel to people
• Physically cruel to animals
• While confronting a victim, has stolen from 
him/her (e.g. mugging)
• Has coerced someone into sexual activity
Destruction of property
• Deliberate engagement in fire setting with the 
intention of causing serious damage
• Deliberate destruction of others’ property
Deceitfulness or theft 
• Housebreaking or breaking into a car or building 
• Frequently lying to obtain favours or goods to 
avoid obligations
• Theft of items of non-trivial value without 
confronting a victim
Serious violations of rules
• Frequently staying out at night despite parental 
prohibitions, beginning before the age of 13 
years
• Has more than once run away from home 
overnight while living in a parental or parental 
surrogate home, or once without returning for a 
lengthy period
• Frequently truant from school
• Aggression 
• Difficulties adhering to rules and 
age-appropriate expectations
• Reluctance to engage positively 
with authority figures; senseless 
resistance and/or open hostility 
and defiance
• Bullying
• Conflict with peers
• Truanting; educational failure
• Serious violation of societal rules; significant 
risk-taking behaviour
• Promiscuity; early sexual debut
• Substance misuse
• Mood instability
• Serious aggression 
• Self-destructive (self-harming) behaviour
• Move into delinquent and/or criminal 
behaviour
• Negative peer associations
• Truanting; educational failure
DSM-V = Diagnostic and Statistical Manual of Mental Disorders (5th edition).
Table 9. Children’s developmental stages of grief[12]
Age (years) View of death
0 - 2 Very limited but realises person not there
3 - 5 Thinks loved one will return; no concept of finality of death
6 - 8 Curiosity about death; magical thinking
9 - 12 Understands finality and irreversibility of death
13 - 18 Understands finality of death
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• There is a further association between behaviour disorders and 
high rates of neurocognitive and neurodevelopmental delay in HIV-
positive children. 
• Two disorders that require specific consideration are conduct 
disorder and oppositional defiant disorder.
Conduct disorder
Definition: a repetitive and persistent pattern of behaviour that violates 
the basic rights of others or where major age-appropriate societal norms 
or rules are transgressed (Table 10).[5]
Oppositional defiant disorder
• Definition: a pattern of argumentative/defiant behaviour and 
angry/irritable mood or vindictiveness lasting at least 6 months. 
• Classification requires exhibition of at least four symptoms from any 
of the categories in Table 11 during an interaction with at least one 
individual who is not a sibling.[5]
Common co-occurring disorders in children with disruptive or 
aggressive behaviour 
Aggressive and disruptive behaviour may present with co-occurring 
difficulties such as:
• ADHD
• Learning disorders and language difficulties
• Intellectual disability
• Anxiety and depressive disorders
• Adjustment disorders
• Substance use disorders
• Trauma-related disorders
• Disruptive mood dysregulation disorder 
• Bereavement 
• Epilepsy 
• Sensory integration difficulties
• Delirium (may be secondary to opportunistic infection or a medication)
• Psychotic disorders
Management of behaviour problems in children and adolescents 
with HIV
• Explore the family’s circumstances, particu larly parenting practices 
and harsh discipline.
• Obtain information from the school and/or recent report cards and 
any other structures that might be involved with the child or the 
family (e.g. social services, justice).
• Establish an alliance with the child and his/her parent/caregiver; try 
not to get drawn into the anger and power struggle that often arises 
out of the child’s behaviour.
• Optimise the management of HIV; ensure adherence to antiretroviral 
medication, establish extent of health and viral suppression and 
ensure that no intercurrent opportunistic infections have arisen. 
• Manage co-occurring problems. These may be more responsive 
to treatment and addressing them may improve the behavioural 
‘dyscontrol’, i.e. aggression, impulsivity and risk-taking behaviours.
• Address learning and educational problems. This may necessitate 
more formal psycho-educational assessment and/or referral to local 
educational authorities, and may be as simple as establishing contact 
with the school and its support structures.
• Refer to social services if there are concerns of neglect or maltreatment, 
child-headed households, poverty, household instability or parental 
illness.
• Encourage participation in prosocial activities and environments in 
the local community (e.g. sports and cultural activities).
• Psychotropic medication may prove useful, but is seldom the 
only solution in addressing behaviour disorders in HIV-positive 
children. Medications are often more successful in treating comorbid 
problems, e.g. methylphenidate for ADHD, anticonvulsants (sodium 
valproate, lamotrigine and carbamazepine) for epilepsy, SSRIs for 
anxiety and depression.
• Seek supervision and get support from your colleagues; working with 
these children and their families can be demoralising and frustrating. 
Management of conduct disorder and oppositional defiant disorder 
in HIV-positive children and adolescents
• Assess family functioning and parenting, and establish that the child 
not been maltreated (physical, emotional or sexual abuse or neglect).
• Refer family to a parenting support group or parenting skills training.
• Refer for individual and/or group psychological intervention, 
depending on the intellectual capacity of the child or adolescent, his/
her capacity to engage in relationship and motivation to participate.
• Risperidone may be useful in reducing aggression and impulsivity, 
but will need to be carefully monitored for the occurrence of EPSE. 
A dose of 0.5 - 1 mg/day, with a maximum dose of 1 - 2 mg daily, is 
recommended. Discuss with a mental health professional if there is a 
poor response to the maximum dosage.
• Mood stabilisers may be used to aid behavioural management and 
affective dysregulation associated with behaviour disorders. These 
should ideally be prescribed by a specialist and monitored carefully.
Table 11. Overview of oppositional defiant disorder
DSM-V criteria Clinical presentation 
• Angry/irritable mood
• Frequently loses temper
• Easily annoyed or touchy
• Often resentful and angry
• Argumentative/defiant behaviour
• Frequently argues with adults and authority figures
• Frequently refuses to comply with requests from authority figures or with rules
• Frequently deliberately annoys others
• Mistakes or misbehaviour frequently blamed on others
• Vindictiveness
• Spiteful or vindictive at least twice within the last 6 months
• Temper outbursts (sometimes referred to as rage attacks in 
younger children)
• Persistent stubbornness; resistance to directions
• Unwillingness to compromise, give in or negotiate with 
adults or peers
• No need to please
• Deliberate or persistent testing of limits 
• Verbal (and minor physical) aggression
• Low self-esteem
• Mood lability and low frustration tolerance
DSM-V = Diagnostic and Statistical Manual of Mental Disorders (5th edition).
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1.8.10 Psychological interventions
1.8.10.1 Psychosocial support for children 
• Psychosocial support can be understood as any type of initiative that 
seeks to protect or promote the well-being of a child or adolescent, 
and prevent or treat mental health problems. 
• It should form part of a broad framework of care that includes 
the family, parents, school and community, and that encompasses 
a range of interventions combined to achieve the best possible 
outcomes. The provision of psychosocial support involves a range of 
stakeholders: caregivers, family members, teachers, and healthcare 
providers including psychological and social services.
• Psychosocial support includes the provision of individual counselling, 
the availability of facility- and community-based support groups, 
parenting programmes and peer support initiatives, and information 
and education workshops.[12] 
• To be effective, psychosocial intervention should be tailored to 
the context and take into account the child’s age and stage of 
development. It is essential that there is focus on enabling an HIV-
positive child to establish their identity, manage their care, live 
positively, cope with challenges and work towards a healthy future. 
• HIV-positive children are particularly vulnerable to psychological 
and social stressors that can affect their development and 
well-being. Psychosocial support can foster resilience, enabling 
children and adolescents to bounce back from adverse experiences 
and to cope better with the multiple stressors related to HIV. 
Their unique psychosocial needs include assistance to deal with 
their illness, help to cope with loss and changes of caregiver, 
and support to overcome isolation associated with stigma and 
discrimination.[12-14] 
1.8.10.2 Therapeutic support 
Psychosocial intervention can take various forms including referral to 
support groups, psychotherapy or counselling (Table 12).[15]
1.8.10.3 Psychosocial support for adolescents 
• Interventions for adolescents fall into three categories: therapeutic 
support, youth-centred interventions and those aimed at fostering 
independence. 
• In the case of the former, support groups, counselling and psychotherapy 
provide support across a broad range of issues (Table 13).[15]
• Group-based interventions are attractive to the adolescent and are a 
time- and cost-effective method of delivery.[15]
1.8.10.4 Benefits of group interventions for adolescents 
• Enhance self-knowledge and self-acceptance.
• Empower individuals to make change.
• Help individuals to develop coping skills.
• Build communication skills and help in relationships outside of the group.
• Give individuals freedom to express negative feelings in a safe, non-
judgemental environment.
• Provide positive reinforcement and emotional support.
• Provide a platform for education, e.g. adherence to treatment.
• Foster a sense of belonging to counter feelings of isolation and 
inadequate social support.
1.8.11 Youth-centred interventions 
• An important aspect of adolescent service provision is ensuring that 
it is youth friendly. 
• Adolescent and Youth-friendly Service (AYFS) provision has been 
identified as an important aspect of service delivery in South Africa, 
and has a strong focus on attracting and retaining young people for 
ongoing care. 
• Adolescents are particularly vulnerable to the harmful outcomes 
of risk behaviours, e.g. unprotected sex and substance abuse, but 
tend not to seek early treatment. There are a number of reasons 
for this, such as worry about stigma or fear of harsh treatment at 
the clinic. 
Table 12. Psychosocial interventions for children
Support groups Psychotherapy Counselling
• Groups need to be tailored to the 
child’s age and stage of development, 
e.g. with younger children play can be 
combined with opportunities to learn 
about healthy living
• Older children can benefit from 
experiential activities across a range of 
health-related topics
• Useful to allow parents and caregivers 
to talk about their own fears, 
frustrations and challenges
• Can address difficulties with 
disclosure. Secrecy can affect the 
mental health of both child and parent/
caregiver
• Provides a forum for education, 
correction of misconceptions and skills 
building
• Useful for building parenting skills that 
can help caregivers to develop effective 
communication skills, set limits and 
discipline appropriately
• Different types of psychotherapy 
are available to address a wide 
range of issues ranging from 
separation anxiety and learning 
or school problems to excessive 
shyness and low self-esteem. The 
choice of therapy will depend on 
the age and stage of the child’s 
development
• In particular, younger children 
may benefit from play therapy 
where the use of play materials 
such as toys and puppets 
encourage children to talk about 
their feelings in order to better 
understand and cope with their 
difficulties
• The participation of children is an important 
aspect of counselling but is easily overlooked. 
Children may also be shut out of conversations 
because they have not been told their status
• Providing the opportunity to talk about 
matters that concern them with someone who 
is empathic, supportive and non-judgemental 
is important
• The following counselling approaches may be 
useful:[16]
• Get down to the child’s eye level
• Speak softly and directly to the child
• Smile and play
• Be honest and patient
• Allow and respect normal emotions
• Start with the least invasive activities
• Give the child choices, e.g. would s/he like 
juice or water with medication
• Engage the child, e.g. talk about hobbies, 
friends and so on
• Support the parent-child relationship. 
• Sit close to the child
 SEPTEMBER 2014, Vol. 15, No. 3   SAJHIVMED     93 
G
U
ID
ELIN
E
• Paying attention to the health needs of adolescents is crucial. As young 
people become more independent, they are expected to take more 
responsibility for their own health. Knowing where and when to get 
help and feeling confident that they can rely on a service that they 
trust and feel is there for them is fundamental to a positive outcome.[16] 
• A package of services should be available to meet the diverse needs 
of young people. 
• It is important to address obstacles that commonly inhibit the use of 
healthcare services by adolescents.
1.8.11.1 Overcoming obstacles to providing AFYS
• Providers should be trained to work competently and respectfully 
with adolescents.
• Services must be confidential, non-judgemental and private.
• Clinic hours should be convenient for young people, e.g. after school.
• Services should be accessible to all adolescents and young people, 
irrespective of their age, sexual orientation or marital status.
• An effective referral system should be in place.
• Opportunities should be made available for young people to be 
involved in the design, implementation and evaluation of the 
programme.
• Services should seek to involve and gain the support of those 
important in the lives of young people and in their communities, e.g. 
partners, parents, school.[16]
1.8.12 Adherence in adolescents 
• Helping adolescents to achieve independence is important 
particularly for those transitioning to adult services. 
• Part of taking increased responsibility for their healthcare involves 
adhering to the prescribed treatment regimen. 
1.8.12.1 Improving adherence in adolescents
• Poor adherence is normal in adolescence, but the risk of drug resistance, 
limited treatment options, increased viral load and risks to survival 
mean that adherence needs to be well supported.
• Reasons for poor adherence among adolescents can be categorised 
into patient, treatment and socioeconomic factors. 
• Stressful life events can contribute to poor adherence, as can 
treatment fatigue, substance abuse and mental health problems such 
as depression. 
• Psychosocial support in the form of counselling, referrals and group 
participation can help young people who are finding adherence 
difficult. Counselling provides opportunities to develop jointly a 
workable treatment plan that includes treatment reminders and takes 
into account lifestyle issues that have the potential to interfere with 
adherence if not addressed. 
• Ideally, adolescents should know their HIV status. Adolescents who 
have not been disclosed to will be unable to appreciate the importance 
of adherence to treatment and are less likely to understand the risks 
associated with engaging in unprotected sex. This makes status 
disclosure an important aspect of care and support.[19]
2.  HIV-associated 
neurocognitive disorders  
2.1 Neurocognitive sequelae
• In untreated children, cognitive impairment occurs early and 
progresses over time, with prevalence rates ranging between 8% 
and 60%. 
• Early invasion of the developing fetal and infant brain is 
believed to result in the most common primary HIV-related 
CNS complication, HIV encephalopathy (HIVE), which refers 
Table 13. Psychosocial interventions for adolescents
Support groups Psychotherapy Counselling
• Three main types of groups 
• Educational
• Social and emotional support 
• Peer-led
• Cost- and time-effective in a busy clinic
• Provide a safe space for young people to 
talk about personal issues, share similar 
challenges, discuss aspects of treatment 
(e.g. adherence), explore coping strategies 
and build a social network
• Can involve novel and interesting ways to 
achieve a specific goal, e.g. music, dance, 
drama, art or storytelling groups 
• Important to understand developmental 
stage to ensure that groups meet the 
particular concerns of different age bands, 
e.g. discussions about puberty (young 
adolescents), or sexual and reproductive 
health issues (older adolescents)
• Support groups conducted for parents 
and caregivers are important and provide 
emotional support for carers, opportunities 
for discussing parenting challenges and 
fostering communication skills to build 
positive family relationships
• The most common types of psychotherapy are 
cognitive behavioural therapy, and interpersonal 
and psychodynamic psychotherapy[17,18] 
• Cognitive behavioural therapy uses techniques 
to correct distortions of thinking that are seen in 
emotional disorders
• Interpersonal psychotherapy is a brief, time-
limited treatment based on the premise that 
depression occurs in the context of relationships. 
It covers four general areas of difficulty: grief, 
conflict in significant relationships, difficulties 
adapting to changes in relationships or life 
circumstances, and problems stemming from 
social isolation
• Psychodynamic psychotherapy is a ‘talk therapy’ for 
adolescents based on understanding issues that are 
behind a young person’s behaviour, thoughts and 
feelings. Not all young people benefit from this form 
of therapy and assessment for suitability is required
• Other types of psychotherapy include family 
therapy, which aims to explore patterns of 
communication in families and to support and 
educate, and dialectical behaviour therapy, which 
is useful with older adolescents with chronic 
suicidal feelings or thoughts
• May involve obtaining advice or 
exploring a personal or social 
problem 
• Positive change more likely in 
a relationship of trust where 
confidentiality is maintained. 
Building trust takes time and 
is greatly facilitated when the 
adolescent is able to see the same 
person at each visit
• Different types of counselling 
include grief, substance abuse and 
adherence counselling
• Adherence counselling is a form 
of psychosocial support that is 
concerned with the identification 
of effective strategies to promote 
adherence to antiretroviral 
treatment. Its aim is to enhance 
the ability of young people to take 
their treatment as prescribed. It is 
a process that includes preparation, 
treatment initiation, consolidation 
and maintenance
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to the disease, damage or malfunction of the brain caused 
by HIV. This complication can be present before significant 
immunosuppression. However, its presence in a child infected 
with HIV constitutes an AIDS-defining illness, reflecting the 
severity of the condition. 
2.1.1  Prevalence and impact of HIV-associated 
neurocognitive disorders (HANDs) in children
Prevalence:
• In untreated HIV-positive children, 8 - 60% experience cognitive 
impairment; disorder occurs early and progresses over time.
• Untreated HIV increases risk of CNS sequelae.[17,20,21]
Impact:
• A range of cognitive deficits occur, cognitive scores clustering in low 
average to borderline range for intellectual functioning. 
• Although cognitive functioning improves after ART initiation, 
scores remain lower than population norms, with poorer academic 
performance and persistence of language (e.g. verbal fluency), 
memory, processing speed, visuospatial and attention problems or 
deficits. Remedial educational interventions are important.[18,22,23]
• Psychosocial stressors (poverty, orphanhood, parental physical/
mental illness or loss) negatively affect adherence, educational and 
mental health outcomes.
• The concept of a milder form of neurocognitive disturbance in HIV-
positive children, such as the adult condition of HAND is recognised 
but is yet to be defined in children and adolescents. This condition 
may have significant effects in functional terms on a child’s learning 
potential.[24]
• Many HIV-positive children receiving ART function within normal 
limits compared with uninfected peers, but a subset with CNS disease 
follow a distinct pattern of low average cognitive functioning. 
• The cognitive deficits in these children may be a result of ongoing 
viral replication in the brain despite virological control in the 
periphery or from residual effects of static HIV-1 CNS disease. 
• Although HIV-positive children receiving highly active antiretroviral 
therapy appear to exhibit global measures of intelligence comparable 
with their uninfected peers, deficits may be present in specific areas 
such as executive functioning and working memory. Deficits in these 
areas can impact significantly on learning. 
• Children with HAND may demonstrate few clinical signs, but an index 
of suspicion should be aroused when history reveals delayed motor 
milestones and when school reports describe school difficulties. 
2.2 Specific neuropsychological deficits 
• Neuropsychological testing reveals that executive functioning deficits 
might be an early indicator of cognitive problems, with deficits in 
mental processing, sequential processing, comprehension, memory, 
visuospatial and time orientation tasks. 
• One or more of the following must be met for diagnosis of HAND:
• A significant drop in cognitive test scores, but generally still 
above the delayed range, with or without mild brain imaging 
abnormalities, with no loss of previously acquired skills and 
no apparent functional deficits (adaptive behaviour and school 
performance stable)
• Cognitive test scores in the borderline range, with no significant 
functional deficits (and no history of significant drop or previous 
testing)
• Cognitive test scores within normal limits (low average range or 
above) with no significant functional deficits and moderate to 
severe brain imaging abnormalities consistent with HIV-related 
changes
• Abnormal neurological findings but not significantly affecting 
function.[26]
• Deficits suggestive of frontal lobe dysfunction (e.g. attention, 
processing speed, motor speed and visuomotor integration) are also 
detectible in HIV-positive children and adolescents. 
• Educational interventions to address these problems are essential to 
improve the overall health literacy (and adherence) in infected youth 
as they age and assume greater treatment responsibility. 
• Children infected with HIV presenting with cognitive problems 
may be slow to process information, slow to complete tasks or 
may be clumsy, and this may affect everyday living. Understanding 
cognition in children is compounded by the fact that developmental 
milestones with regard to motor function, co-ordination and the 
elements of cognition occur at various stages in the development 
of a child. Screening tools used in adults such as the International 
HIV Dementia Scale in their current form are thus inappropriate in 
children and adolescents, as each tool must accommodate the different 
developmental stages from childhood through to adolescence. 
2.3  Identification and management of 
neurocognitive disorders
• Prevention of HIVE, HAND and AIDS-defining conditions via 
early ART remains the cornerstone of effective management. ART 
has dramatically decreased the prevalence of HIVE in the US from 
35 - 50% to <2%.[27]
• Furthermore, early initiation of ART results in improved 
neurodevelopmental outcomes compared with deferred initiation. 
• Ensuring adherence and providing treatment support are key factors 
in management.
• A multidisciplinary, tiered approach is recommended for the 
management of neurocognitive complications (Table 14). 
• Referral for pure neurocognitive decline should immediately be to a 
paediatrician/physician, according to the age of the child. 
• However, concern about contributing mental health/behavioural 
issues may require psychiatric review.
Centers for Disease Control and Prevention: HIV encephalopathy 
criteria for classification[25]
Must include at least one of the following for at least 2 months in the 
absence of a concurrent illness:
• Failure to attain or loss of developmental milestones or loss of 
intellectual ability, verified by standard developmental scale or 
neuropsychological tests
• Impaired brain growth or acquired microcephaly evident by head 
circumference measurements or brain atrophy demonstrated by 
computed tomography or magnetic resonance imaging; serial 
imaging is required for children <2 years of age
• Acquired symmetric motor deficit manifested by two or more 
of the following: paresis, pathological reflexes, ataxia or gait 
disturbance
Cognition refers to a group of mental processes that include atten-
tion, memory, producing and understanding language, learning, 
reasoning, problem-solving and decision-making.
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• If cognitive impairment develops once a child is receiving ART, check 
viral load and adherence.
• If a child’s milestones are deteriorating or if an older child has 
educational or behaviour problems, and there is no obvious 
explanation, the child should be referred for further evaluation even 
if HIV infection is well suppressed. 
• Treatable conditions can be diagnosed at a primary healthcare level; 
routine history, examination and blood tests assist in this regard 
(Table 15).
• Exclude indirect complications of HIV infection such as opportunistic 
infections (tuberculous meningitis, cytomegalic virus infection), and 
intrauterine exposure to alcohol and substances. 
Table 14. Management of HIV-positive children at primary, secondary and tertiary care levels
Primary • Document milestones, and measure head circumference at birth, enrolment and 6-monthly thereafter
• Monitor growth and nutrition
• Actively investigate and manage treatable conditions, e.g. chronic middle ear infection, epilepsy, iron deficiency 
anaemia
• Review copies of school reports, and refer for educational support, if possible
• Monitor side-effects of medication, e.g. sleep disturbances
• Refer to secondary level healthcare if complicated epilepsy, positive diagnosis of HIVE, or if HAND, attention or 
behavioural problems are suspected
Secondary • Paediatricians, psychiatrists, physiotherapists, occupational therapists and speech therapists at secondary level must 
be made available to all primary healthcare workers for up-referral as necessary
• Strengthen links between educators (teacher or learning support professionals at the school) and health professionals in 
order to provide education goals that are realistic and that will ensure the child achieves his/her maximum potential
• Refer for screening by specialists to decide if tertiary intervention is required and to manage some of the more 
complex general medical problems
Tertiary • Refer for assessment by a specialist paediatrician (or developmental paediatrician)
• Refer for neuroimaging
• Refer to a psychologist for cognitive testing and/or neuropsychological battery (if indicated)
• Refer for EEG if indicated
• Refer for occupational therapy, audiology, and assessment of language and speech therapy as needed
• Referral for audiometry if a language development delay is present
HIVE = HIV encephalopathy; HAND = HIV-associated neurocognitive disorder; EEG = electroencephalography.
Table 15. Medical conditions that may affect cognition[28,29]
Condition Diagnosis
Potential effect on 
cognition Management
Iron deficiency anaemia History and full blood count Attention problems Iron supplements
Nasal obstruction History, sleep studies Learning difficulties and 
attention problems
Nasal spray, referral to an ENT specialist
Chronic middle ear 
infection
History and examination Decreased hearing 
resulting in learning 
difficulties
Audiology, referral to an ENT specialist
Visual impairment History and examination (e.g. 
use of a Snellen chart for older 
children and small items such 
as edible ‘100s and 1 000s’ for 
young children)
Visuomotor problems and 
difficulty managing in the 
classroom
Refer to an optometrist/ophthalmologist as 
appropriate
Malnutrition Growth charts Specific learning 
difficulties and attention 
problems
Referral to a dietician, medical follow-
up, refer to a nutrition supplementation 
programme
Efavirenz side-effects Sleep history and colateral 
from teacher, may sleep at 
school, high efavirenz level
Decreased concentration 
and focus, poor memory
Detailed history, consider lower dose 
(discuss with a specialist)
Emotional problems History and behaviour 
checklists
Cognitive problems, 
attention problems, poor 
scholastic performance
Refer to a psychiatric service
ENT = ear, nose and throat.
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• Identify environmental and socioeconomic deprivation (orphans, 
poverty, malnutrition), as this may further affect cognition.
• If other factors (e.g. behavioural, acute illness, other infection) may 
possibly explain the drop in scores or low cognitive functioning, 
do not classify as HAND or encephalopathy; re-evaluate at a later 
stage.
2.3.1  Screening tools to detect neurocognitive 
impairment
• No international validated screening tools are available to test HIV-
positive children for neurocognitive impairment. 
• However, screening tools can be helpful in identifying children 
at risk for developmental problems. Examples of simple tools 
that can be used are available to download online (http://www.
sahivsoc.org/topics?page=1&currentFilter=Mental%20Health). 
These include a tool for children younger than 5 years and 
another for schoolgoing children. These tools have not been 
validated, but together with the Road to Health Developmental 
Check List (RTHDCL) may provide local tools for use at primary 
and secondary level care. 
• We recommend that all children be screened 6-monthly and more 
formally at 3 - 4 years and again at 5 - 6 years. This, together with 
the RTHDCL, should enable flagging of children with potential 
problems. Early detection of problems paves the way for interventions 
that would improve the quality of life of these children.
• Screening should occur in the context of general HIV clinics across 
all levels of healthcare. 
• Screening needs to include a history, formal systemic examination and 
particularly a neurological examination (at least head circumference 
and motor examination, deep tendon reflexes and gait assessment). 
• Any child with delayed developmental milestones should be referred 
for further assessment. 
• It is important to identify contributing factors that can be managed, e.g. 
nutritional, emotional, poverty and deprivation factors, among others.
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